Abomics is a Finnish health technology company founded in 2013, specializing in pharmacogenetics. We support clinicians by providing practical tools that enable safe prescribing and personalized healthcare.
Abomics' journey
From our beginnings in Finland to becoming a trusted provider of pharmacogenetic solutions, Abomics has grown through innovation, collaboration, and a commitment to safe and personalized healthcare. Explore the milestones that have shaped our path.
First databases
Multirec introduced its drug interactions and drug-laboratory effects databases and began delivering to a leading EHR provider in Finland.
2000
2013
Abomics founded
Abomics Oy was established in Turku, Finland by medical doctors Jari Forsström and Klaus Elenius. The company had a vision to bring pharmacogenetics into everyday clinical decision-making. From the start, the company combined healthcare expertise with health IT know-how.
First sample handled
Abomics handled its first pharmacogenetic sample.
2014
2014
International expansion begins
Abomics initiated global expansion by partnering with a laboratory in Estonia.
First PGx database released
Abomics launched its pharmacogenetic database in collaboration with Duodecim Publishing Company Ltd, making gene-drug interaction data available to Finnish doctors.
2015
2021
International growth
Abomics solutions adopted in multiple European countries.
Multirec joins Abomics group
Multirec Oy, Finland’s leading provider of medicinal product databases, became part of Abomics Group, strengthening EHR integration and clinical decision support capabilities.
2022
2022
PGx interpretation platform expanded
Abomics enhanced its interpretation service, integrating with major EMR and LIMS systems and broadening medication coverage beyond 100 drugs.
ISO 13485:2016 certification achieved
Abomics obtained ISO 13485:2016 certification through Kiwa Inspecta, ensuring compliance with international quality and safety standards.
2023
2025
PGx integration in Finnish health systems
Ostrobothnia Wellbeing Services County became the first to integrate Abomics’ pharmacogenetic data into patient record systems, marking a major step toward nationwide adoption.
ISO 13485:2016 certification renewed
Abomics successfully renewed its ISO 13485:2016 certification through SGS Fimko, reaffirming commitment to international quality and safety standards.
2025
Our commitment
Promoting health through pharmacogenetics
At Abomics, we help healthcare professionals make safer and personalized treatment decisions by providing clear and reliable pharmacogenetic insights integrated directly into clinical workflows.
Built by clinicians, for clinicians
Founded by medical professionals, we bring real clinical experience into everything we do. With over 10 years of PGx interpretation expertise, our solutions are designed to support daily decision-making in real-world care.
Grounded in science and evidence
Our services are based on scientific research and global guidelines like CPIC, DPWG, EMA, and FDA. We update our databases and interpretation engine regularly to keep our recommendations accurate and actionable.
Certified for quality and safety
We operate under a certified Quality Management System (ISO 13485:2016) and follow strict risk management standards. Our solutions are safe, transparent, and built for reliability.
Join us in shaping the future of personalized medicine
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
